BAY-Y-5959

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBAY-Y-5959
Drug Alias NameBAY-Y-5959
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel agonists
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsMyocardial IschemiaHeart FailureArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaHeart FailureArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A